![]() ![]() Learning what is important to patients from the patients themselves is essential to create a core outcome set to bridge the gap between the patients’ needs and the current OA management paradigms. To accomplish this, a consensus about the outcomes that are relevant to OA patients, comorbid populations, and other key stakeholders in OA requires listening to patients’ opinions and experiences. However, there is increasing interest in developing OA interventions that improve physical health and quality of life (QoL) while reducing opioid or NSAID abuse and associated comorbidities. Greater disability is often associated with a decrease in mental health and an increase in mortality when a person can no longer walk or live independently. Adults afflicted with OA display different degrees of disability, ranging from mild and intermittent pain, with minimal difficulty in performing daily activities, to chronic pain with progressive structural damage and loss of function. In Latin America, the numbers of adults with OA are only partially available. Of these, more than 40 million adults live in Europe, and over 30 million in the United States of America (USA). ![]() Worldwide, around 300 million people suffer from OA. From 1990 to 2013, the trend of Years Lived with Disabilities (YLD) in OA increased 75%, being OA the third most rapidly rising condition after diabetes and dementia. Globally, osteoarthritis (OA) is the most common musculoskeletal disorder and it is associated with pain, disability, and quality-adjusted life-year losses. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |